GSK1940029, CAS 1150701-66-8

Formulation: A solid

Formal Name: 1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-1H-1,2,3-triazole-4-carboxamide

Purity: ≥98%

Formula Markup: C18H16Cl2N4O2

Formula Weight: 391,3

Shelf life (days): 1460

CAS Number: 1150701-66-8

Notes: GSK1940029 is a stearoyl-CoA desaturase (SCD) inhibitor.{66417} It increases palmitate-induced phosphorylation of p70 ribosomal S6 kinase 1 (p70S6K1) and lactate dehydrogenase (LDH) release from AML12 hepatocytes when used at a concentration of 20 µM.{66418} GSK1940029 (10 µM) also increases palmitate-induced increases in extracellular and intracellular triglyceride levels in AML12 hepatocytes, an effect that can be reversed by the mammalian target of rapamycin (mTOR) inhibitor torin 1 (Item No. 10997).

• Artikelnummer: CAY36704-25
• Hersteller: Cayman Chemical
• Hersteller Artikelnummer: 36704-25
• Verpackungseinheit: 25 mg
• Mengeneinheit: STK
• Methode: Reinstoffe